This inventor holds 1 USPTO granted patent. Top assignee: Ecole Polytechnique Federale De Lausanne. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: François Majo: Innovator in Ophthalmic Technology
Introduction
François Majo is a notable inventor based in Pully, Switzerland. He has made significant contributions to the field of ophthalmic technology, particularly in the development of contact lenses designed to treat ocular inflammatory pathologies. His innovative approach combines advanced materials with therapeutic agents to enhance patient care.
Latest Patents
Majo holds a patent for an "Ophthalmic contact lens with compressible affinity matrix." This invention relates to a contact lens that utilizes a soft porous material, which can be coupled with detoxifying agents. The design allows for effective contact with inflammatory mediators present in the tear fluid of patients suffering from ocular pathologies. The unique architecture of the lens promotes greater contact area and fluid exchange, improving treatment outcomes.
Career Highlights
François Majo is affiliated with the École Polytechnique Fédérale de Lausanne, a prestigious institution known for its cutting-edge research and innovation. His work has garnered attention for its potential to revolutionize the treatment of eye conditions, showcasing his commitment to advancing medical technology.
Collaborations
Majo collaborates with esteemed colleagues, including Amélie Barbara Hildegarde Béduer and Thomas Braschler. Their combined expertise contributes to the development of innovative solutions in the field of ophthalmology.
Conclusion
François Majo's contributions to ophthalmic technology exemplify the impact of innovation in healthcare. His patented contact lens represents a significant advancement in the treatment of ocular inflammatory conditions, highlighting the importance of research and collaboration in medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
